VLX-1570

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVLX-1570
Drug Alias NameVLX-1570
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin specific peptidase 14 inhibitorsUbiquitin C-terminal hydrolase L5 inhibitors
TargetsUbiquitin C-terminal hydrolase L5Ubiquitin specific peptidase 14
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVivolux Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivolux Ab
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A